Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goldenseal-Metformin Interaction in Type 2 Diabetes
NCT05081583Phase 1Completed
- Sponsor
- Washington State University
- Start
- Sep 2021
- Primary completion
- Jan 2023
- Countries
- 1
01
Overview
Phase 1, open-label trial (3 arms), sponsored by Washington State University. Primary endpoints: Metformin Area Under the Plasma Concentration-Time Curve and Metformin Maximum Plasma Concentration. Started Sep 2021; status: completed.
Beyond the preview
Go deeper on NCT05081583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05081583.